NIDDK

Engineered bacteria that produce beneficial compounds — and that could potentially be administered in foods like yogurt — may be a future treatment for obesity and other chronic diseases.

Physician-scientists are uniquely positioned to help solve some of the nation’s most formidable health challenges, Jeff Balser, MD, PhD, told college students from across the country last week during a conference hosted by VUMC.

Understanding the roles of various immune cells that reside in the gut lining could shed light on inflammatory bowel diseases.

Microtubules — part of the cell's cytoskeleton — regulate the secretion of insulin, suggesting that they may be a new target for treating diabetes.

Men are more susceptible to progressive kidney disease than women; new VUMC studies point to differences in the expression and activation of the EGF receptor.

A new imaging method makes it possible to directly measure cell division and changes in metabolism in atherosclerotic plaques.

Vanderbilt researchers have discovered that the gut microbiome composition modulates how dietary nutrients are metabolized, with potential downstream consequences on metabolic health.